Pharma
The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.
The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."
Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.
The collaboration will offer low-cost medications to employees and employers through a new platform dubbed EmsanaRx Plus.
The company said it will use the capital to hire for its commercial teams and advance development on new features.
Data containing accurate medication history and prescription fill insights can lead to better patient outcomes, says Dr. Colin Banas, CMO of health IT company DrFirst.
PointClickCare's senior health-focused datasets will help to influence Pfizer's decisions on new therapies.